JP2002531539A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531539A5 JP2002531539A5 JP2000586677A JP2000586677A JP2002531539A5 JP 2002531539 A5 JP2002531539 A5 JP 2002531539A5 JP 2000586677 A JP2000586677 A JP 2000586677A JP 2000586677 A JP2000586677 A JP 2000586677A JP 2002531539 A5 JP2002531539 A5 JP 2002531539A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- convulsions
- ischemia
- syndrome
- bladder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010010904 Convulsion Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 6
- 208000028867 ischemia Diseases 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 206010048994 Bladder spasm Diseases 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 3
- 201000003883 Cystic fibrosis Diseases 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062016 Immunosuppression Diseases 0.000 description 3
- 206010022562 Intermittent claudication Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000005107 Premature Birth Diseases 0.000 description 3
- 206010036590 Premature baby Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 208000021386 Sjogren Syndrome Diseases 0.000 description 3
- 208000030886 Traumatic Brain injury Diseases 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 3
- 206010047163 Vasospasm Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 3
- 201000008980 hyperinsulinism Diseases 0.000 description 3
- 230000001506 immunosuppresive effect Effects 0.000 description 3
- 208000021156 intermittent vascular claudication Diseases 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 206010027599 migraine Diseases 0.000 description 3
- 201000006938 muscular dystrophy Diseases 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 201000003631 narcolepsy Diseases 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- 208000023504 respiratory system disease Diseases 0.000 description 3
- 201000009881 secretory diarrhea Diseases 0.000 description 3
- 230000009529 traumatic brain injury Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000003274 myotonic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000030761 polycystic kidney disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK199801609 | 1998-12-04 | ||
| DKPA199801609 | 1998-12-04 | ||
| PCT/DK1999/000680 WO2000034228A1 (en) | 1998-12-04 | 1999-12-03 | Ion channel modulating agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531539A JP2002531539A (ja) | 2002-09-24 |
| JP2002531539A5 true JP2002531539A5 (https=) | 2007-02-01 |
Family
ID=8106516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586677A Pending JP2002531539A (ja) | 1998-12-04 | 1999-12-03 | イオンチャネル調節剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6458846B1 (https=) |
| EP (1) | EP1133467B1 (https=) |
| JP (1) | JP2002531539A (https=) |
| AT (1) | ATE276232T1 (https=) |
| AU (1) | AU1549700A (https=) |
| DE (1) | DE69920259T2 (https=) |
| WO (1) | WO2000034228A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3811775B2 (ja) | 2000-07-19 | 2006-08-23 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | ４−ヨードフェニルアミノベンズヒドロキサム酸の酸素化エステル |
| EP1345618B1 (de) * | 2000-12-28 | 2005-03-23 | Switch Biotech Aktiengesellschaft | Chlorzoxazon zur behandlung von psoriasis |
| DE10250870A1 (de) * | 2002-10-31 | 2004-05-13 | Switch Biotech Ag | Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung |
| ES2277273T3 (es) * | 2003-05-16 | 2007-07-01 | Wyeth | Derivados de oxima de aril-carbaldehido, y su utilizacion como agentes estrogenicos. |
| MY150088A (en) | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
| NZ546011A (en) | 2003-10-21 | 2009-09-25 | Warner Lambert Co | Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| EP2528440A4 (en) | 2010-01-27 | 2013-08-07 | Purdue Research Foundation | SUBSTITUTED NORINDEN ISOCHINOLINE, SYNTHESIS THEREOF AND METHOD OF USE THEREOF |
| PL227238B1 (pl) * | 2015-03-02 | 2017-11-30 | Politechnika Warszawska | Sposób wytwarzania 5-alkilosalicylaldoksymów i zastosowanie |
| CN114262282B (zh) * | 2021-12-16 | 2024-04-19 | 广东省科学院资源利用与稀土开发研究所 | 一种醛肟类化合物及其制备方法和应用 |
| WO2025026555A1 (en) * | 2023-08-02 | 2025-02-06 | Universidad Pública de Navarra | Aldoximes as no donors, and their uses as plant architecture modifiers and in therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4347372A (en) * | 1978-09-01 | 1982-08-31 | Ciba-Geigy Corporation | Benzoxazolyl-glyoxylonitrile-2-oxime ether derivatives |
| DD235450B1 (de) * | 1983-12-29 | 1988-02-03 | Humboldt Uni Z Berlin | Verfahren zur herstellung neuer 1-(2-hydroxyaryl)-alkan-1-on-oxime |
| GB8617648D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Fungicides |
| WO1995001157A1 (en) * | 1993-06-29 | 1995-01-12 | The Procter & Gamble Company | Use of hydroxyphenyl oximes as chelating photoprotectants |
| US5840758A (en) * | 1996-06-06 | 1998-11-24 | Abbott Laboratories | Oxime derivatives of fenamates as inhibitors of prostaglandin biosynthesis |
| WO1999037149A1 (en) * | 1998-01-27 | 1999-07-29 | Brigham & Women's Hospital | Methods of treating cytotoxic damage |
-
1999
- 1999-12-03 AU AU15497/00A patent/AU1549700A/en not_active Abandoned
- 1999-12-03 AT AT99957966T patent/ATE276232T1/de not_active IP Right Cessation
- 1999-12-03 JP JP2000586677A patent/JP2002531539A/ja active Pending
- 1999-12-03 DE DE69920259T patent/DE69920259T2/de not_active Expired - Lifetime
- 1999-12-03 EP EP99957966A patent/EP1133467B1/en not_active Expired - Lifetime
- 1999-12-03 WO PCT/DK1999/000680 patent/WO2000034228A1/en not_active Ceased
-
2001
- 2001-05-15 US US09/854,554 patent/US6458846B1/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002531552A5 (https=) | ||
| JP2002531539A5 (https=) | ||
| AU4768999A (en) | Potassium channel blocking agents | |
| ATE285769T1 (de) | Verwendung von isatinderivaten als ionenkanalaktivierende mittel | |
| JP2002519412A5 (https=) | ||
| JP2008520745A5 (https=) | ||
| EP2817288B1 (en) | Processes for the preparation of (s)-1-(3-ethoxy-4methoxyphenyl)-2-methanesulfonylethylamine | |
| JP2006523596A5 (https=) | ||
| RU2003104827A (ru) | Получение ароматических карбоновых кислот | |
| AU2004234588A1 (en) | Production of hydrocarbons by steam reforming and Fischer-Tropsch reaction | |
| JP4700603B2 (ja) | 部分酸化改質器−改質交換器配列 | |
| TW371294B (en) | Continuous non-polluting liquid phase titanium dioxide process a non-polluting liquid-phase process and a supporting system of apparatus for producing titanium dioxide from titanium ore or slag provide a more economical sulfate process for preparing anatase | |
| JP2007517896A5 (https=) | ||
| US7998430B2 (en) | Production of synthetic rutile by continuous leaching | |
| CN106082136B (zh) | 一种硫磺回收尾气冷凝分离设备 | |
| US4518425A (en) | Production of magnesium metal | |
| HU184318B (en) | Process for reducing iron content of raw materialsprocess for decreasing the iron content of raw mat containing iron, silicon and aluminium, as well aerials conta ining iron, silicon and aluminium ands for producing in the given case aluminium oxide for preparing iron oxide further in a given case aluminium oxide concentrate concentrate | |
| CN106946887A (zh) | 一种引入催化剂优化合成双嘧达莫的新工艺 | |
| CN102271505A (zh) | (2-氨基)-四氢咔唑-丙酸的合成 | |
| JP2009542602A5 (https=) | ||
| CN113387975B (zh) | 一种热缩合法生产苯基氯硅烷的方法 | |
| Choi et al. | An deletion/insertion polymorphism of the angiotensin converting enzyme gene in ischemic stroke patients | |
| CA1219451A (en) | Production of magnesium metal | |
| Groziak | Six-membered ring systems: diazines and benzo derivatives | |
| CN110655480A (zh) | 一种砜类化合物的合成方法 |